STOCK TITAN

Teknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Alpha Teknova, Inc. (TKNO) will report its financial results for Q4 and full year 2023 on March 11, 2024. A webcast and conference call will be held at 5:30 p.m. Eastern Time.
Positive
  • None.
Negative
  • None.

HOLLISTER, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2023, on Monday, March 11, 2024, following the close of market.

Teknova will host a webcast and conference call on Monday, March 11, 2024, beginning at 5:30 p.m. Eastern Time. Participants can access the live webcast on the Investor Relations section of the Teknova website and at this link: https://edge.media-server.com/mmc/p/qqayy3wz. To receive a PIN number for dial in, participants can register for the webcast via this link: https://register.vevent.com/register/BI6c01344c805a4906b6dc3b443dd64af3. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Teknova   
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel therapies that will help people live longer, healthier lives. Teknova offers fully customizable solutions for every stage of the workflow, supporting industry leaders in cell and gene therapy, molecular diagnostics, and synthetic biology. The Company’s fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps their customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 200,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by its team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of novel therapies. 

Investor Contacts 
Matt Lowell 
Chief Financial Officer 
matt.lowell@teknova.com
+1 831-637-1100

Media Contact 
Jennifer Henry  
Senior Vice President, Marketing 
jenn.henry@teknova.com  
+1 831-313-1259


FAQ

When will Alpha Teknova, Inc. report its financial results for Q4 and full year 2023?

Alpha Teknova, Inc. will report its financial results for the fourth quarter and full year ended December 31, 2023, on Monday, March 11, 2024.

What time will the webcast and conference call be held on March 11, 2024?

The webcast and conference call will begin at 5:30 p.m. Eastern Time on Monday, March 11, 2024.

Where can participants access the live webcast?

Participants can access the live webcast on the Investor Relations section of the Teknova website and at the following link: https://edge.media-server.com/mmc/p/qqayy3wz.

How can participants receive a PIN number for dial-in?

Participants can register for the webcast via the following link to receive a PIN number for dial-in: https://register.vevent.com/register/BI6c01344c805a4906b6dc3b443dd64af3.

When will the webcast be available for replay?

The webcast will be available for replay on the Company's website approximately two hours after the event.

Alpha Teknova, Inc.

NASDAQ:TKNO

TKNO Rankings

TKNO Latest News

TKNO Stock Data

419.53M
10.58M
9.33%
80.45%
0.51%
Drug Manufacturers - Specialty & Generic
In Vitro & in Vivo Diagnostic Substances
Link
United States of America
HOLLISTER